InvestorsHub Logo
Followers 393
Posts 64207
Boards Moderated 3
Alias Born 08/20/2000

Re: Profe$$or post# 102189

Friday, 07/31/2009 1:36:37 PM

Friday, July 31, 2009 1:36:37 PM

Post# of 137481
XOMA u picking up this news yet? (COMTEX) B: Xoma wins $1.7 million subcontract from SRI International ( Da
tamonitor )
B: Xoma wins $1.7 million subcontract from SRI International ( Datamonitor )

Jul 31, 2009 (Datamonitor via COMTEX) --
Xoma, a biopharmaceutical company, has received a new $1.7 million
subcontract from SRI International to produce novel antibody drugs against
the virus that causes severe acute respiratory syndrome or SARS, a highly
contagious infectious disease that often progresses to pneumonia and may be
fatal.

The project is funded under a 2006 prime contract between SRI, a nonprofit
scientific research institute based in Menlo Park, California and the
National Institute of Allergy and Infectious Diseases (NIAID), part of the
National Institutes of Health.

Xoma's responsibilities will include the evaluation of several antibodies
for growth, productivity, manufacturability and performance in bioreactors.
Xoma may receive additional awards under this five year contract.

Previously, NIAID has awarded three contracts for a total of nearly $100
million to Xoma to develop anti-botulism antibodies. The first product
candidate resulting from this work, XOMA 3AB, is currently undergoing
pre-investigational new drug studies studies.

Steven Engle, chairman and CEO of Xoma, said: "We are pleased that Xoma has
been selected for this important new project. Currently, the federal
government is funding another key project under which we will develop and
evaluate antibody products to the botulinum neurotoxin, with the goal of
entering into a long-term manufacturing and stockpiling contract."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon
Copyright (C) 2009 Datamonitor. All rights reserved
*** end of story ***


THE STANDOFF

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.